Host-Directed Therapies for Tuberculosis

Host-Directed Therapies for Tuberculosis.jpg

Dublin Core

Title

Host-Directed Therapies for Tuberculosis

Subject

TUBERCULOSIS

Description

TB is considered as one of the oldest documented infectious diseases in the world and is believed to be the leading cause of mortality due to a single infectious agent. Mtb, the causative agent responsible for TB, continues to afflict millions of people worldwide. Furthermore, one-third of the entire world's population has latent TB. Consequently, there has been a worldwide effort to eradicate and limit the spread of Mtb through the use of antibiotics. However, management of TB is becoming more challenging with the emergence of drug-resistant and multi-drug resistant strains of Mtb. Furthermore, when administered, many of the anti-TB drugs commonly present severe complications and side effects. Novel approaches to enhance the host immune responses to completely eradicate Mtb infection are urgently needed. This Special Issue will therefore cover most recent advances in the area of host-directed therapies for TB.

Creator

Venketaraman, Vishwanath (editor)

Source

https://directory.doabooks.org/handle/20.500.12854/69310

Publisher

MDPI - Multidisciplinary Digital Publishing Institute

Date

2020

Contributor

Sulistiorini

Rights

https://creativecommons.org/licenses/by/4.0/

Relation

1. Rachel Abrahem, Ruoqiong Cao, Brittanie Robinson, Shalok Munjal, Thomas Cho,
Kimberly To, David Ashley, Joshua Hernandez, Timothy Nguyen, Garrett Teskey
and Vishwanath Venketaraman
Elucidating the Efficacy of the Bacille Calmette–Gu´erin Vaccination in Conjunction with First
Line Antibiotics and Liposomal Glutathione
Reprinted from: J. Clin. Med. 2019, 8, 1556, doi:10.3390/jcm8101556
2. Afsal Kolloli, Pooja Singh, G. Marcela Rodriguez and Selvakumar Subbian
Effect of Iron Supplementation on the Outcome of Non-Progressive Pulmonary
Mycobacterium tuberculosis Infection
Reprinted from: J. Clin. Med. 2019, 8, 1155, doi:10.3390/jcm8081155 .
3. Meng-Rui Lee, Ming-Chia Lee, Chia-Hao Chang, Chia-Jung Liu, Lih-Yu Chang, Jun-Fu
Zhang, Jann-YuanWang and Chih-Hsin Lee
Use of Antiplatelet Agents and Survival of Tuberculosis Patients: A Population-Based
Cohort Study
Reprinted from: J. Clin. Med. 2019, 8, 923, doi:10.3390/jcm8070923
4. Chin-Chung Shu, Shih-Chieh Chang, Yi-Chun Lai, Cheng-Yu Chang, Yu-Feng Wei and
Chung-Yu Chen
Factors for the Early Revision of Misdiagnosed Tuberculosis to Lung Cancer: A Multicenter
Study in A Tuberculosis-Prevalent Area
Reprinted from: J. Clin. Med. 2019, 8, 700, doi:10.3390/jcm8050700
5. Steve Ferlita, Aram Yegiazaryan, Navid Noori, Gagandeep Lal, Timothy Nguyen, Kimberly
To and Vishwanath Venketaraman
Type 2 Diabetes Mellitus and Altered Immune System Leading to Susceptibility to Pathogens,
Especially Mycobacterium tuberculosis
Reprinted from: J. Clin. Med. 2019, 8, 2219, doi:10.3390/jcm8122219

Format

Pdf

Language

English

Type

Text

Identifier

DOI
10.3390/books978-3-03943-502-9

ISBN
9783039435012, 9783039435029

Document Viewer